Reach out today to see if Tirzepatide is the right choice for you
On the EPIC Study website, it specifically states: "Currently there is no treatment licensed to delay the onset of CHF [congestive heart failure]." Elsewhere on the EPIC Study website it states: "There is currently no treatment licensed for the management of preclinical, myxomatous mitral valve disease (MMVD)." And still on another page of the EPIC Study website it states: "Treatment of CHF due to MMVD begins when the dog shows clear clinical signs of heart failure, and is tailored for the individual dog." As you see, pimobendan's own manufacturer repeatedly warns against giving the drug to dogs before they are in heart failure
Gastrointestinal side effects, affecting up to 50% of GLP-1 users, significantly reduce treatment adherence
ANZ J Surg
What a BUD actually represents A Beyond-Use Date is the date after which a compounded medication should not be used
Common side effects of GLP-1 agonists include nausea, diarrhea, stomach pains, constipation, lowered appetite, low blood sugar, and headaches